ApoA-I Milano (AIM): Began Phase I trial

Esperion Therapeutics Inc. (ESPR), Ann Arbor, Mich.
Product: ApoA-I Milano (AIM)
Business:

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE